2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 40.664 | 31.166 | 98.993 | 195.327 | 89.274 | 41.632 | 35.514 | 40.559 | 25.331 | 21.857 |
Total Income - EUR | 40.664 | 31.166 | 99.016 | 195.327 | 89.275 | 41.633 | 35.514 | 42.516 | 25.331 | 21.938 |
Total Expenses - EUR | 22.216 | 14.714 | 64.143 | 131.114 | 51.441 | 17.818 | 12.651 | 12.729 | 9.123 | 13.075 |
Gross Profit/Loss - EUR | 18.448 | 16.452 | 34.873 | 64.213 | 37.833 | 23.814 | 22.863 | 29.787 | 16.208 | 8.862 |
Net Profit/Loss - EUR | 17.228 | 15.517 | 31.903 | 60.413 | 36.940 | 22.709 | 21.848 | 28.594 | 15.604 | 8.643 |
Employees | 0 | 0 | 1 | 1 | 2 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Antitetic S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 161 | 379 | 94 | 0 | 1.205 | 394 | 0 | 854 | 1.630 | 3.239 |
Current Assets | 22.840 | 35.789 | 65.863 | 80.655 | 49.313 | 29.446 | 27.369 | 30.366 | 16.334 | 8.428 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 16.163 | 23.747 | 44.204 | 66.087 | 41.731 | 23.674 | 18.597 | 24.955 | 14.130 | 5.824 |
Cash | 6.677 | 12.042 | 21.660 | 14.568 | 7.583 | 5.773 | 8.772 | 5.412 | 2.204 | 2.604 |
Shareholders Funds | 17.273 | 32.934 | 31.957 | 60.722 | 36.992 | 22.760 | 21.898 | 28.643 | 15.653 | 10.089 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 5.728 | 3.234 | 34.000 | 19.933 | 13.527 | 7.080 | 5.471 | 2.578 | 2.332 | 1.578 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7311 - 7311" | |||||||||
CAEN Financial Year |
7311
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Antitetic S.r.l.